Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer †.

Despite consensus guidelines, most patients with early-stage triple-negative (TN) and HER2-positive (HER2+) breast cancer do not see a medical oncologist prior to surgery and do not receive neoadjuvant chemotherapy (NAC). To understand barriers to care, we aimed to characterize the relationship betw...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 31; no. 8; pp. 4728 - 4746
Autores principales:	Yee, Elliott K., Hallet, Julie, Look Hong, Nicole J., Nguyen, Lena, Coburn, Natalie, Wright, Frances C., Gandhi, Sonal, Jerzak, Katarzyna J., Eisen, Andrea, Roberts, Amanda
Formato:	Journal Article
Publicado:	MDPI Aug2024
Acceso en línea:	Ver este registro en EBSCOhost